Boehringer Ingelheim received approval to expand the label claims for its NexGard brands for the treatment of two severe skin diseases in dogs. Both NexGard and NexGard Spectra are now approved for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results